Skip to content
Sunday, December 22, 2024
Wall Street Insider
Deliver critical advise to busy investors
Search
Search
News
About Us
Services
Institutional Research
Portfolio Analysis
#1 Stock Pick
Subscriptions
Contact Us
CLIENT LOGIN
Home
News
Verastem shares surge more than 50% after pancreatic-cancer treatment study data
News
Verastem shares surge more than 50% after pancreatic-cancer treatment study data
May 23, 2024
Arthur Bleemer
Shares of Verastem rose late Thursday after interim data from the company’s trial evaluating a combination therapies to treat pancreatic cancer showed a high overall response rate.
Read more from source
Post navigation
New energy sources for AI, data centers are vital to U.S. national security
J.P. Morgan Securities to pay $200 million to settle CFTC charges of supervision failures